GO
Loading...

Medicine

More

  • New HPV vaccine strengthens cancer protection Wednesday, 10 Dec 2014 | 3:22 PM ET

    WASHINGTON— The drugmaker Merck& Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer. The FDA said Wednesday the updated Gardasil has the potential to prevent roughly 90 percent of cervical, vulvar, vaginal and anal cancers.

  • Merck advancing breast cancer drug to mid-stage Wednesday, 10 Dec 2014 | 12:54 PM ET

    TRENTON, N.J.— Drugmaker Merck& Co. said Wednesday that it will advance a new cancer drug into bigger patient tests, after promising findings in an early study against a very aggressive, common type of breast cancer. Merck, based in Kenilworth, New Jersey, said it will start mid-stage patient tests of Keytruda in the first half of 2015. It's received accelerated...

  • Arca's potential Ebola drug gets "orphan drug status" Wednesday, 10 Dec 2014 | 11:19 AM ET

    Dec 10- Arca Biopharma Inc said the U.S. Food and Drug Administration granted its experimental drug orphan drug status as a potential treatment for viral hemorrhagic fever after exposure to the Ebola virus. The Westminster, Colorado- based company, whose stock rose about 11 percent on Wednesday, joins a list of drugmakers looking for ways to fight the largest...

  • A rust belt city rehab plan designed in medicine Tuesday, 9 Dec 2014 | 12:54 PM ET
    SmartShape Design industrial designers at work.

    The loss of manufacturing has crushed rust belt cities like Cleveland, but a medical renaissance has helped city businesses to rebound.

  • This data represents a "quantum leap" in the management of this disorder by shifting from "life-long symptom management to once-and-done cures," Roth Capital Partner's Debjit Chattopadhyay said, raising his price target on the stock to $90 from $50. LentiGlobin's results read-through favorably to the sickle-cell indication, Piper Jaffray analysts said,...

  • CHICAGO, Dec 9- The U.S. Department of Health and Human Services on Tuesday offered liability protections to drugmakers rushing to develop Ebola vaccines and urged other countries to follow suit. Health and Human Services Secretary Sylvia Burwell made the announcement as part of the Public Readiness and Emergency Preparedness Act in a move aimed at...

  • CHICAGO, Dec 8- The United States has suspended imports of live and raw poultry from the Canadian province of British Columbia due to an outbreak of bird flu virus, the U.S. Department of Agriculture's chief veterinary officer told Reuters on Monday. The restrictions began on Dec. 4, the same day that Canada identified the virus as a "highly pathogenic" H5N2 strain,...

  • Amgen's bone drug Xgeva gets new approval Monday, 8 Dec 2014 | 11:21 AM ET

    NEW YORK— Amgen's Xgeva, which is used to treat bone disorders related to cancer, received an additional U.S. marketing approval. Amgen said hypercalcemia of malignancy is considered an orphan disease, meaning there are fewer than 200,000 patients in the U.S. Shares of Amgen Inc. rose $2.21 to $171.45 in morning trading.

  • In Ebola outbreak, bad data adds another problem Monday, 8 Dec 2014 | 10:15 AM ET

    Bruce Aylward, who is leading the World Health Organization's Ebola response, said it's crucial to track every single Ebola patient in West Africa to stop the outbreak and that serious gaps remain in their data. "Decisions about prevention and treatment should be data-driven, but we really don't have the data," agreed Irwin Redlener, director of the National...

  • LONDON, Dec 8- Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks. The Spark program is expected to enter early-stage clinical trials for hemophilia B in the first half of 2015. Spark will be responsible for the early Phase I/II tests, with...

  • For kids with autism, a 'flight' to ease stress Sunday, 7 Dec 2014 | 3:03 AM ET

    LINTHICUM, Maryland— With boarding passes in hand, children with autism spectrum disorders and their families took part in an air travel rehearsal at Baltimore-Washington International Thurgood Marshall Airport. Fifty families experienced a typical day at an airport, from check-in and security to receiving peanuts and pretzels from flight attendants...

  • Dec 6- Eighty-seven percent of Hodgkin lymphoma patients responded to a Bristol-Myers Squibb drug that helps the immune system fight the blood cancer, according to data from a small, early stage trial released on Saturday. Margaret Shipp, co-lead investigator of the Checkmate-039 study from Dana-Farber Cancer Institute in Boston. The results were being...

  • Dec 6- Merck& Co Inc's drug that harnesses the immune system to fight cancer showed promise in Hodgkin lymphoma patients whose disease had progressed following prior therapies, according to data from a small, early stage trial being presented at a medical meeting. Craig Moskowitz, the study's principal investigator from Memorial Sloan Kettering Cancer...

  • Dec 3- U.S. health regulators on Wednesday approved an Amgen Inc drug that helps the immune system fight a rare type of leukemia, more than five months ahead of the expected decision date. Anthony Stein, professor of hematology at City of Hope outside Los Angeles who worked on clinical trials of blinatumomab, called the approval "very important" for patients.

  • Dec 2- The U.S. Food and Drug Administration changed the rules governing how prescription drugs and biologics used during pregnancy and breastfeeding are labeled. The decision, which has been in the works since 2008, will impact more than 6 million pregnancies in the United States involving women who, on average, need to take three to five prescription drugs...

  • Dec 2- Avian influenza, known as bird flu, has killed thousands of turkeys and chickens on two farms in the province of British Columbia, the Canadian Food Inspection Agency said on Tuesday. Germany, the Netherlands and Britain reported cases last month of the highly pathogenic bird flu H5N8, which is similar to one that devastated poultry flocks in South Korea...

  • FDA panel says newer HIV tests effective Tuesday, 2 Dec 2014 | 5:00 PM ET

    Dec 2- Newer methods to test donated blood samples for HIV infections are effective, a panel of experts at the U.S. Food and Drug Administration concluded, in a move that could limit the ban on donations by men who have had sex with other men. The FDA's ban, in place for about three decades, disallows donations from men who have had sex with even one man since 1977, as they...

  • Dec 2- Biogen Idec Inc's research chief on Tuesday said the company is planning a late-stage trial of its experimental treatment for Alzheimer's disease after the drug cut brain plaque levels and significantly improved cognition in a small early-stage study. Brain swelling has been a recurrent issue with experimental anti-amyloid Alzheimer's drugs,...

  • Dec 2- Biogen Idec Inc's research chief on Tuesday said the company was planning a late-stage trial of its experimental treatment for Alzheimer's disease after the drug cut brain plaque levels and improved cognition in a small early-stage study. Shares of Biogen were up 6.8 percent in morning trading on the Nasdaq. Douglas Williams said at the Deutsche Bank...

  • Dec 1- The U.S. Food and Drug Administration lifted a clinical hold on Flexion Therapeutics Inc's lead experimental drug to relieve osteoarthritis-related pain, allowing the company to resume its mid-stage trial. Osteoarthritis is one of the most common forms of arthritis in the United States and affects about 27 million Americans. Up to Monday's close,...